CaTe is currently developing a Digital Therapeutic (DTx) for remote cardiac rehabilitation. Their product enables heart disease patients to conduct cardiac rehabilitation using standing exercise safely and effectively even in a limited space like at home without the use of ergometers or similar devices.
Company name
CaTe, Inc.
Type of business
Medical(medical devices, drug discovery)
Representatives
Kazuhiro Terashima
Establishing a company
March 2020
Investment announcement date
August 2025
Capitalist
Mayumi Beppu
HP
https://cate.co.jp/Phasing
Early
